Kim JH - Search Results

1

Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability.

Kim NG, Rhee H, Li LS, Kim H, Lee JS, Kim JH, Kim NK, Kim H. Kim NG, et al. Among authors: kim h, kim nk, kim jh. Oncogene. 2002 Aug 1;21(33):5081-7. doi: 10.1038/sj.onc.1205703. Oncogene. 2002. PMID: 12140758

2

Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors.

Kang HJ, Nam SW, Kim H, Rhee H, Kim NG, Kim H, Hyung WJ, Noh SH, Kim JH, Yun CO, Liu ET, Kim H. Kang HJ, et al. Among authors: kim h, kim ng, kim jh. Oncogene. 2005 Feb 3;24(6):1066-74. doi: 10.1038/sj.onc.1208358. Oncogene. 2005. PMID: 15690055

3

VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.

Yoo JY, Kim JH, Kwon YG, Kim EC, Kim NK, Choi HJ, Yun CO. Yoo JY, et al. Among authors: kim nk, kim jh, kim ec. Mol Ther. 2007 Feb;15(2):295-302. doi: 10.1038/sj.mt.6300023. Mol Ther. 2007. PMID: 17235307 Free article.

4

Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung.

Kang SM, Kang HJ, Shin JH, Kim H, Shin DH, Kim SK, Kim JH, Chung KY, Kim SK, Chang J. Kang SM, et al. Among authors: kim h, kim sk, kim jh. Cancer. 2007 Feb 1;109(3):581-7. doi: 10.1002/cncr.22413. Cancer. 2007. PMID: 17186532 Free article.

5

Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma.

Lee YJ, Park IK, Park MS, Choi HJ, Cho BC, Chung KY, Kim SK, Chang J, Moon JW, Kim H, Choi SH, Kim JH. Lee YJ, et al. Among authors: kim h, kim sk, kim jh. J Cancer Res Clin Oncol. 2009 Dec;135(12):1647-54. doi: 10.1007/s00432-009-0611-7. Epub 2009 Jun 11. J Cancer Res Clin Oncol. 2009. PMID: 19517135

6

ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.

Yun CO, Kim E, Koo T, Kim H, Lee YS, Kim JH. Yun CO, et al. Among authors: kim e, kim h, kim jh. Cancer Gene Ther. 2005 Jan;12(1):61-71. doi: 10.1038/sj.cgt.7700769. Cancer Gene Ther. 2005. PMID: 15375379

7

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.

Kim JH, Lee YS, Kim H, Huang JH, Yoon AR, Yun CO. Kim JH, et al. Among authors: kim h. J Natl Cancer Inst. 2006 Oct 18;98(20):1482-93. doi: 10.1093/jnci/djj397. J Natl Cancer Inst. 2006. PMID: 17047197 Free article.

8

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.

Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO. Lee YS, et al. Among authors: kim h, kim jh. Clin Cancer Res. 2006 Oct 1;12(19):5859-68. doi: 10.1158/1078-0432.CCR-06-0935. Clin Cancer Res. 2006. PMID: 17020994 Free article.

9

Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.

Kim HS, Shin SJ, Kim JH, Kim H, Choi HJ. Kim HS, et al. Among authors: kim h, kim jh. Tohoku J Exp Med. 2013 Sep;231(1):21-8. doi: 10.1620/tjem.231.21. Tohoku J Exp Med. 2013. PMID: 23994910 Free article. Clinical Trial.

10

Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity.

Yun CO, Yoon AR, Yoo JY, Kim H, Kim M, Ha T, Kim GE, Kim H, Kim JH. Yun CO, et al. Among authors: kim h, kim m, kim ge, kim jh. Hum Gene Ther. 2005 Feb;16(2):248-61. doi: 10.1089/hum.2005.16.248. Hum Gene Ther. 2005. PMID: 15761264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,382 results

Search Page

Filters